Pityriasis versicolor
Therapeutic area
Dermatology
Rare disease
No
- Definition
- A yeast infection usually manifested as a superficial skin infection. It may also present as a systemic infection in patients who are receiving total parenteral nutrition.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Pityriasis versicolor
- Therapeutic area
- Dermatology
- pityriasis versicolor
- Malassezia furfur infection
- infections, Malassezia furfur
- tinea versicolor
- Severity
- Mild
- Acquired
- Inflammatory
- Dermatology
- Infectious Disease
- MONDO ID
- MONDO:0005915
- Parent condition
- MONDO:0005982
Related records
Broader conditions (18)
- Cutaneous mycosis
- Dermatitis
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Exanthem
- Fungal infectious disease
- Human disease
- Infectious disease
- Inflammatory disease
- Integumentary system disorder
- Skin disorder
- Skin disorder caused by infection
- Skin infection
- Superficial mycosis
- Tinea infection
Trials (16)
- 8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor
- A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.
- A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor
- A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor
- Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
- Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
- Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor
- Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor
- Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor
- Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.
- Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).
- Gene Polymorphism in Tinea Versicolor
- Ketoconazole Foam 2% for the Treatment of Versicolor
- Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor
- The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial
- Vitamin D Level in Recurrent PV
Drugs in development (3)
- Fluconazole Phase 1
- Itraconazole Phase 2
- Ketoconazole Phase 1
Other linked drugs (1)
- Econazole